[1]
P.-G. Everardo, G.-S. Magdalena, G.-P. . Maria Elena, C.-M. Vanessa, and S.-C. Gabriela, “Bioavailability assessment of fexofenadine and montelukast in a fixed-dose combination tablet versus the components administered simultaneously”, Allergol Immunopathol, vol. 49, no. 4, pp. 15–25, Mar. 2021, doi: 10.15586/aei.v49i4.89.